SCHOOL OF MEDICINE  |  PITT HOME  |  FIND PEOPLE  |  FIND A DOCTOR AT UPMC

Department of Medicine

Department of Medicine

  Division of Pulmonary, Allergy and Critical Care Medicine



[Return To Index page]
photo David O. Wilson, MD, MPH

Associate Professor of Medicine, Cardiothoracic Surgery, and Clinical & Translational Science

Associate Director, Lung Cancer Center, Hillman Cancer Center

Director, Georgia Cooper Memorial Lung Nodule/Lung Cancer Research Registry

Email: wilsondo@upmc.edu

Phone: 412-687-3355

Contact
Office: UPMC Cancer Pavillion
5150 Centre Ave. Ste. 4c
Pittsburgh, PA 15232
 
Phone: 412-687-3355
Fax: 412-623-3303
E-mail: wilsondo@upmc.edu
Administrative Assistant:
Rasheeda Patton
Email: pattonr@upmc.edu
Phone: 412-687-3355
Fax: 412-623-3303
Education and Training
Education
BA, The Johns Hopkins University, 1976
MD, University of Pittsburgh School of Medicine, 1980
MPH, Graduate School of Public Health, 1986
Training
Residency, Internal Medicine, University Health Centers of Pittsburgh, 1983
Fellowship, Pulmonary and Critical Care, University Health Centers of Pittsburgh, 1985
Fellowship, Pulmonary & Occupational Medicine, University Health Centers of Pittsburgh, 1985
Research Interest
Dr. Wilson’s research interests include: Lung Cancer screening and chemoprevention, diagnosis, staging and treatment; COPD, especially as it relates to lung cancer; Occupational Lung Diseases; General Pulmonary Medicine; and Nutrition support. His main current focus is the development of predictive tools, beyond emphysema for risk stratification for lung cancer screening. This work includes risk prediction formulas, surrogate tissue biomarkers and imaging biomarkers.
Clinical Interest
Dr. Wilson is the Director of the Georgia Cooper Lung Nodule/Cancer Proteomics/Genomics Research Registry and Associate Director of the Lung Cancer Center of the Hillman Cancer Center of the University of Pittsburgh Cancer Institute. He is the lead clinician for the Pittsburgh Lung cancer Screening Study (PluSS) and co-investigator for the Pittsburgh Lung Cancer SPORE.
He is the principal investigator in Pittsburgh for the Iloprost Chemo-prevention trial. He is the Director of the Nutrition Support Service at UPMC-Shadyside Hospital. He introduced endobronchial ultrasound (EBUS) to Pittsburgh and has a longstanding interest in lung cancer staging and treatment.
Publications
For my complete bibliography, Click Here.
Selected Publications:
Wilson, DO, Weissfeld, JM. A simple model for predicting lung cancer occurrence in a lung cancer screening program: The Pittsburgh Predictor. Lung Cancer. Lung Cancer. 2015; 89: 31-37.
De Torres, JP, Wilson, DO, Sanchez-Salcedo, P, Weissfeld, JL, Berto, J, Campo, A, Alcaide, AB, Garcia-Granero, M, Celli, BR, Zulueta, JJ. Lung cancer in COPD patients: development and validation of the COPD Lung Cancer Screening Score (COPD-LUCSS). A J Resp Crit Care Med. 2015; Feb 1: 191(3): 285-91.
Sanchez-Salcedo, P, Wilson, DO, De Torres, JP, Weissfelf, J, Berto, J, Campo, A, Alcaide, AB, Pueyo, J, Bastarrika, G, Seijo, L, Pajaras, M, Pio, R, Montuenga, L, Zulueta, JJ. Improving selection criteria for lung cancer screening: The potential role of emphysema. AJ Resp Crit Care Med. 2015; 191: 924-931.
Wilson, DO. Systematic review: Lung cancer screening with low-dose CT (LDCT) is ready for prime time in the USA. Evid Based Med. 2014; 19:4: 150.
Wilson, DO, Leader, JK, Fuhrman, C, Reilly, JJ, Sciurba, F, Weissfeld, J. Quantitative CT analysis, airflow obstruction and lung cancer in the Pittsburgh Lung Screening Study. J Thor Onc. 2011; 6: 1200-05.
Gu, S, Wilson, DO, Tan, J, Pu, J. Pulmonary nodule registration: Rigid or nonrigid ?. Med Phys. 2011; 38: 4406-4414.
Wilson, DO, Ryan, A, Fuhrman, C, Schuchert, MJ, Shapiro, S, Siegfried, JM, Weissfeld, J. Doubling times and CT screen detected lung cancers in the Pittsburgh Lung Screening Study (PLuSS). AJRCCM. 2012; 185: 85-89.
Wilson, D, Weissfeld, J, Balkan, A, Fuhrman, C, Fisher, S, Wilson, J, Siegfried, J, Shapiro, S, Sciurba, F. Association of radiographic emphysema and chronic airflow obstruction with lung cancer risk. AJRCCM. 2008; 178: 738-744.
Wilson, D, Weissfeld, J, Fuhrman, C, Fisher, S, Balogh, P, Landreneau, R, Luketich, J, Siegfried, J. The Pittsburgh Lung Cancer Screening Study (PluSS): Outcomes within 3 years of prevalence CT scan. AJRCCM. 2008; 178: 956-961.
Gilbert, S, Wilson, DO, Christie, NA, Pennathur, A, Luketich, JD, Landreneau, RJ, Close, JM, Schuchert, MJ. Endobronchila Ultrasound as a Diagnostic Tool in Patients with Mediastinal Lymphadenopathy. Ann Thor Surg. 2009; 88: 896-902.
Sponsored Research/Activities
Title: Clinical and Molecular Profiles of Smokers with Subclinical Interstitial Lung Disease
Role: Co-Investigator
Funding Agency: Harvard University/National Heart, Lung, & Blood Institute
Grant Number: R01 HL129920
Start Year: 2015
End Year: 2018
Title: Biomarkers Predictive of Lung Function in Decline in Physiologically Normal Smokers
Role: Co-Investigator
Funding Agency: National Heart, Lung, & Blood Institute
Grant Number: R21 HL129917
Start Year: 2015
End Year: 2017
Title: SPORE in Lung Cancer Project 3: Lung Cancer Risk Prediction in the Pittsburgh Lung Screening Study
Role: Co-Investigator
Funding Agency: National Cancer Institute
Grant Number: P50 CA090440
Start Year: 2011
End Year: 2016
Title: SPORE in Lung Cancer Project 2: Vitamin D Modulation of Inflammation and Lung Cancer Risk
Role: Co-Investigator
Funding Agency: National Cancer Institute
Grant Number: P50 CA090440
Start Year: 2001
End Year: 2016